Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1989-8-17
|
pubmed:abstractText |
Iotrolan was used in concentrations of 240 and 300 mg I/ml for indirect lymphography in a total of 70 patients, and permitted a diagnostic evaluation of the peripheral lymphatics in all cases. The contrast quality was found to correlate with the concentration used. The concentration of 300 mg I/ml Iotrolan was judged to provide the better contrast density and definition. Side effects were limited to transient local erythema and pain during the infusion in one patient and a protracted reaction resembling serum sickness in another patient (Iotrolan 240 mg I/ml). Because of its excellent tolerance, Iotrolan is particularly suitable after subepidermal infusion for indirect lymphography, during which the local lymph drainage of cutaneous regions of interest can be evaluated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0178-4609
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
128
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
178-81
|
pubmed:dateRevised |
2008-2-26
|
pubmed:meshHeading |
pubmed-meshheading:2568790-Clinical Trials as Topic,
pubmed-meshheading:2568790-Contrast Media,
pubmed-meshheading:2568790-Dose-Response Relationship, Drug,
pubmed-meshheading:2568790-Double-Blind Method,
pubmed-meshheading:2568790-Humans,
pubmed-meshheading:2568790-Iodobenzoates,
pubmed-meshheading:2568790-Lymphedema,
pubmed-meshheading:2568790-Lymphography,
pubmed-meshheading:2568790-Triiodobenzoic Acids
|
pubmed:year |
1989
|
pubmed:articleTitle |
Indirect lymphography with iotrolan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|